Design and Implementation of the Pediatric Liver Transplantation Biobank
NCT04477967 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2020-07-20
Summary
The purpose of the pediatric liver transplant biobank is to systematically collect clinical specimens from pediatric end-stage liver disease. It is expected to contribute to the research and development of paediatric end-stage liver disease in the future.
Conditions
- Liver Diseases
- Liver Transplant; Complications
- Pediatric ALL
Interventions
- OTHER
-
No intervention
There are no interventions because it is a protocol study
Sponsors & Collaborators
-
Children's Hospital of Chongqing Medical University
lead OTHER
Eligibility
- Min Age
- 1 Month
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-10-01
- Primary Completion
- 2021-01-01
- Completion
- 2028-07-01
Countries
- China
Study Locations
More Related Trials
-
Transfusional Iron Overload Among Leukemia Survivors
NCT01965171 ·Status: COMPLETED
-
Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP)
NCT06715267 ·Status: RECRUITING
-
Critical Illness After Hematopoietic Cell Transplantation
NCT07328724 ·Status: NOT_YET_RECRUITING
-
Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database
NCT01353677 ·Status: COMPLETED
-
Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study
NCT06708130 ·Status: RECRUITING
-
National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia
NCT07019766 ·Status: RECRUITING
-
Effect of BM-MSCs in DCD Kidney Transplantation
NCT02561767 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Improving Blood Stem Cell Collection and Transplant Procedures
NCT01517035 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Lung Function in Children Who Have Undergone Bone Marrow Transplantation
NCT00009711 ·Status: COMPLETED
-
Long-term Follow-up After Adoptive Transfer of Genetically Modified Cell Products
NCT05713214 ·Status: RECRUITING
-
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation
NCT06702111 ·Status: RECRUITING
-
Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance
NCT01690247 ·Status: UNKNOWN ·Phase: PHASE1
-
Biomarker Study for Prediction of aGVHD
NCT03614143 ·Status: UNKNOWN
-
Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia
NCT04174586 ·Status: UNKNOWN ·Phase: PHASE1
-
Gene Therapy for X Linked Severe Combined Immunodeficiency
NCT04286815 ·Status: UNKNOWN ·Phase: NA
-
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia
NCT05335226 ·Status: UNKNOWN ·Phase: NA
-
Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT
NCT02988258 ·Status: SUSPENDED ·Phase: PHASE1
-
Clinical Study on the Impact of Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell Transplantation
NCT05587881 ·Status: WITHDRAWN
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT
NCT07047456 ·Status: RECRUITING ·Phase: PHASE3
-
Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia
NCT01050036 ·Status: COMPLETED ·Phase: NA
-
CMV Infection and Immune Intervention After Transplantation
NCT04320303 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia.
NCT05752123 ·Status: TERMINATED ·Phase: NA
-
CIBMTR Research Database
NCT01166009 ·Status: RECRUITING
-
Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogeneic HSCT
NCT02873325 ·Status: TERMINATED
-
Immune Reconstitution to CMV After HSCT: Impact of Clinical Factors and Therapy Strategies
NCT05656599 ·Status: ENROLLING_BY_INVITATION